Introduction
The tumorigenesis of sporadic endometrial cancer, the most common gynecological malignancy encountered in western countries, is commonly explained on the basis of a dualistic model that discriminates between Type I endometrial endometrioid carcinoma (EEC) and Type II non-endometrial endometrioid carcinoma tumors from both biological and clinical parameters (1) . EECs represent the majority of cases of sporadic endometrial cancer (70-80%) with unopposed estrogen stimulation as the etiological factor associated with the development of the carcinoma (2) . EECs usually develop in pre-and perimenopausal women, express estrogen and progesterone receptors (3) and are associated with elevated levels of serum estradiol (4) . Histologically, most tumors are of low grade, they are frequently preceded by endometrial hyperplasia and, overall, they are characterized by a favorable prognosis. Nonetheless, deep myometrial invasion correlates with more undifferentiated tumors, lymph-vascular invasion, node affectation and decreased global survival. As the initial event in tumor invasion and distant dissemination, myometrial infiltration determines an increase in the rate of recurrence after a first surgical treatment and a decrease in survival at the 5 year follow-up (5) .
Despite the characterization of molecular events associated with the development of endometrial carcinoma, those associated with the early steps of infiltration and invasion in endometrial cancer are still unknown. The molecular pathology of myometrial infiltration that defines the initial steps of invasion in endometrial cancer correlates with the downregulation of E-cadherin as a main player of epithelial to mesenchymal transition, as well as modifications on other molecules involved in cell-cell contacts that render cells with a migratory phenotype. In addition, altered signaling pathways and transcription factors correlate with myometrial invasion, histological grade and metastasis (5) .
One of these transcription factors involved in endometrial cancer invasion is the Ets family member ERM/ETV5, described specifically as being upregulated in EEC associated with myometrial infiltration (6) . Ets family members have been correlated to tumor progression by upregulating the expression of matrix-degrading proteases. The acquisition of a migratory phenotype by the epithelial tumor cells together with the remodeling of the extracellular matrix must accompany the process of cancer cell invasion. Indeed, ERM/ETV5 has been shown to act through matrix metalloproteinase-2 gelatinolytic activity to confer invasive capabilities, associated with an initial switch to myometrial infiltration (7) .
Proteomic approaches to the molecular interactions underlying pathophysiological states within the field of cancer research are nowadays unraveling protein networks that play pivotal roles in the establishment and maintenance of the hallmarks of malignancy, including cell invasion and migration. To understand the role of the transcription factor ERM/ETV5 during myometrial infiltration, we analyzed by two-dimension differential gel electrophoresis (2D-DIGE) technology those proteins whose expression was altered in endometrial cell lines stably overexpressing ERM/ETV5, thus presumably under the control of its transcriptional activity. Specific deregulation of a reduced group of proteins indicated changes in actin cytoskeleton or RNA processing. Interestingly, functional studies demonstrated an association between endometrial cancer invasion promoted by ERM/ETV5 and oxidative stress through the induction of Hep27, a member of the superfamily of short-chain dehydrogenases/reductases (SDRs).
Two-dimension differential gel electrophoresis A pool consisting of equal amounts of each of the samples analyzed in a 2D-DIGE experiment was prepared to be used as internal standard for quantitative comparisons (8) . The triplicates from each Hec-1A, Hec-1A GFP and Hec-1A GFP-ERM/ETV5 cell lines were labeled with Cy3 and Cy5 cyanine dyes, whereas internal standard pooled sample was labeled with Cy2 dye, by the addition of 400 pmol of Cy dye in 1 ll of anhydrous N,N-dimethylformamide per 50 lg of protein. To avoid any possible bias introduced by labeling efficiency, the samples from each group were alternatively labeled with both Cy3 and Cy5 dyes. After 30 min incubation on ice in the dark, the reaction was quenched with 10 mM lysine and further incubated for 10 min. Samples were finally combined according to the experimental design, at 50 lg of protein per Cy dye per gel, and diluted 2-fold with IEF sample buffer (7 M urea, 2 M thiourea, 4% wt/vol CHAPS, 2% dithiothreitol, 2% pharmalytes pH 3-10 and 0.002% bromophenol blue). The 2-dimension electrophoresis was performed using GE Healthcare reagents and equipment. First dimension isoelectric focusing was performed on immobilized pH gradient strips (24 cm; linear gradient pH 3-10) using an Ettan immobilized pH gradientphor system. Firstly, strips were incubated overnight in 450 ll of rehydration buffer (7 M urea, 2 M thiourea, 4% wt/vol CHAPS, 1% pharmalytes pH 3-10, 100 mM DeStreak and 0.002% bromophenol blue). Then, samples were applied via cup loading near the acidic end of the strips. After focusing at a global voltage of 67 kV, strips were equilibrated first for 15 min in 6 ml of reducing solution [6 M urea, 100 mM TrisHCl pH 8, 30% vol/vol glycerol, 2% wt/vol sodium dodecyl sulfate (SDS), 5 mg/ ml dithiothreitol and 0.002% bromophenol blue] and then in 6 ml of alkylation solution (6 M urea, 100 mM Tris-HCl pH 8, 30% vol/vol glycerol, 2% wt/vol SDS, 22.5 mg/ml iodoacetamide and 0.002% bromophenol blue) for 15 min, on a rocking platform. Second-dimension SDS-polyacrylamide gel electrophoresis were run by overlaying the strips on 12.5% isocratic Laemmli gels (24 Â 20 cm), casted in low fluorescence glass plates on an Ettan DALTsix system. Gels were run at 20°C at constant power 2.5 W per gel for 30 min followed by 17 W per gel until the bromophenol blue tracking front reached the end of the gel.
Fluorescence images of the gels were acquired on a Typhoon 9400 scanner (GE Healthcare, Buckinghamshire, UK). Cy2, Cy3 and Cy5 images were scanned at 488/520, 532/580 and 633/670 nm excitation/emission wavelengths, respectively, at a 100 lm resolution. Image analysis and statistical quantification of relative protein abundances were performed using DeCyder V. 6.0 software (GE Healthcare).
Protein identification by mass spectrometry Protein spots were excised from the gel using an automated Spot Picker (GE Healthcare). In-gel trypsin digestion was performed as described (9) using autolysisstabilized trypsin (Promega, Madison, WI). Tryptic digests were purified using ZipTip microtiter plates (Millipore, Cork, Ireland). Matrix-assisted laser desorption/ionization-mass spectrometry analysis (MALDI/MS) of tryptic peptides was performed on an Ultraflex time of flight (TOF)-TOF Instrument (Bruker, Bremen, Germany). Samples were prepared using a-cyano-4-hydroxy-cinnamic acid as matrix on anchor-chip targets (Bruker). Identification of the proteins was carried out by peptide-mass fingerprinting data and/or by TOF-TOF post source decay fragmentation spectra. Database searches were performed using the MASCOT program (Matrix Science, Boston, MA). Alternatively, proteins were confirmed or identified by ion trap mass spectrometry as described (10) Signaling pathways analysis Functional pathway and network analyses were generated through the use of Ingenuity pathway analysis (version 2.0, IngenuityÒ Systems, Mountain View, CA). Ingenuity pathway analysis identified those canonical pathways, biological processes and gene interaction networks that were most significant to the proteins selected from the 2D-DIGE analysis. Each protein designation was mapped in the Ingenuity Pathways Knowledge Base. Proteins that met the expression ratio cutoff of 1.3, a P-value cutoff of 0.005 for differential expression, and were associated with a canonical pathway in the Ingenuity Pathways Knowledge Base were considered for the analysis.
Western blot and subcellular fractionation Whole protein extracts were prepared as described (7) . Proteins separated in SDS-10% polyacrylamide gels and transferred onto nitrocellulose membranes were then incubated with primary antibodies 1/400 monoclonal antibody (mAb) anti-actin (NeoMarkers, Lab Vision Corporation, Westinghouse Drive, Fremont, CA), 1:500 rabbit polyclonal antibody (rAb) antibody mitogen-activated protein kinase (Millipore, Billerica, MA), 1/1500 mAb anti-Hep27 (11) and 1/100 rAb ERM/ETV5 (Santa Cruz Biotechnology, Santa Cruz, CA) and developed with horseradish peroxidaseconjugated rabbit anti-mouse and goat anti-rabbit immunoglobulins (DAKO, Glostrup, Denmark) and the SuperSignalÒ West Dura substrate (Pierce Biotechnology, Rockford, IL).
Alternatively, mitochondrial, cytosolic and nuclei fractions were obtained by differential centrifugation of Hec-1A and Hec-1A GFP-ERM/ETV5 homogenates. Cells were trypsinized, pelleted, washed with phosphate-buffered saline (PBS) and then redissolved in ice-cold isolation buffer containing 0.3 M mannitol, 0.1% bovine serum albumin, 0.2 mM ethylenediaminetetraacetic acid, 10 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid, adjust pH at 7.4 and protease inhibitors (Sigma-Aldrich, St Louis, MO). Cells were homogenized on ice and were centrifuged 1000g at 4°C for 10 min. The pellets with nuclei were stored at À80°C until used for SDS-polyacrylamide gel electrophoresis, while the supernatants were collected and further centrifuged 14 000g for 15 min at 4°C. The resulting supernatants were considered as the cytosolic fraction, while the pellets with the mitochondrial fraction were washed twice with cold isolation buffer. Each fraction was redissolved in Laemmli's loading buffer and proteins were separated as described.
Immunofluorescence Hec-1A, Hec-1A GFP and Hec-1A GFP-ERM/ETV5 cells cultured on coverslips were fixed with 4% paraformaldehyde for 15 min and permeabilized for 30 min in PBS 0.1% saponin. Cells were sequentially incubated with 1/100 rAb ERM/ETV5 and with anti-rabbit secondary antibodies conjugated with tetramethyl rhodamine isothiocyanate (Sigma) for 1 hr at room temperature in dark. Alternatively, Hec-1A GFP-ERM/ETV5 cells were fixed with methanol for 6 min at À20°C and incubated with 1/10 mAb Hep27 and with anti-mouse secondary antibody conjugated with 488-alexa fluor (Molecular Probes, Invitrogen, Paisley, UK) for 1 h at room temperature in dark. Coverslips were mounted using the Vectashield mounting medium (Vector Laboratories, CA), and fluorescence was visualized and imaged on a DM-IRBE inverted fluorescence microscope (Leica, Wetzlar, Germany) coupled to a TCS-NT argon/krypton confocal laser (Leica).
Finally, Hec-1A GFP-ERM/ETV5 cells were incubated with growth medium containing 250 nM MitoTrackerÒ (Molecular Probes) for 45 min at 37°C and then rinsed three times with PBS before processing for Hep27 localization at the mitochondria.
Immunohistochemistry Paraffin-embedded sections from human endometrial carcinomas and from tumors originated from Hec-1A and Hec-1A GFP-ERM/ETV5 cells and orthotopically implanted in mice (7), were stained for Hep27 pattern of expression by indirect immunoperoxidase assay. Sections were treated with heat in 1 mM ethylenediaminetetraacetic acid pH 8 buffer for antigen retrieval, and endogenous peroxidase activity was quenched with 3% H 2 O 2 . Sections were incubated overnight with the primary antibody against Hep27 at a 1:300 dilution, washed and incubated with peroxidase conjugated goat anti-mouse immunoglobulin (EnVision Dual System, DAKO, Glostrup, Denmark). Subsequently, sections were washed, and reactions were developed with diaminobenzidine, followed by counterstaining with hematoxylin. Quantitative evaluation of Hep27 cytoplasmic immunostaining on nine different fields per orthotopic tumor section ($30 000 cells) was performed by three independent investigators.
Chromatin immunoprecipitation Chromatin immunoprecipitation on Hec-1A GFP-ERM/ETV5 cells was performed with rAb ERM/ETV5 as described (7). Rabbit acetyl-Histone H4 (Upstate, Lake Placid, NY) was used as positive control. For PCR analysis, 1 ll of input DNA extraction and 10 ll of immunoprecipitated DNA were used for 40 cycles of amplification (annealing temperature 60°C), with the following primers for Hep27: reverse primer, 5#-CAGAAAAGGCCTCACCCACAAC-3# and forward primer, 5#-TCTTTC-CACAAGCAGCAAGCAGC-3#.
Oxidative stress Hec-1A and Hec-1A GFP-ERM/ETV5 were treated with 1 lM H 2 O 2 (Sigma Chemical Co., Oakville, Canada) for 30 min and allowed to recover for 5 h before protein extraction and processing for western blotting. Alternatively, cells were treated with 50 mM N-acetyl-L-cystein (Sigma) for 4 h, before the extraction of protein lysates.
For the fluorescence detection of superoxide, Hec-1A and Hec-1A GFP-ERM/ETV5 cells cultured on coverslips were incubated for 20 min at 37°C in fresh fetal bovine serum-free McCoy's medium containing 10 lM dihydroethidium (DHE; Invitrogen). Upon removal of the medium and wash with PBS, fluorescence was directly monitored on an Olympus fluorescence microscope Proteomic approach to endometrial carcinoma invasion (excitation 510 nm, emission 590 nm). Alternatively, to quantify the formation of red fluorescent oxidation products, Hec-1A and Hec-1A GFP-ERM/ETV5 cells treated with DHE were collected, washed and resuspended in PBS and analyzed with the help of a flow cytometer (FacsCalibur, BD Biosciences).
Small interfering RNA transfection and apoptosis assay Hec-1A GFP-ERM/ETV5 cells were transfected with 100 mM negative control or with Hep27 small interfering RNA (siRNA) (Hep27 #1 siRNA: s19887, Hep27 #2 siRNA: s19888; DHSR2 SilencerÒ Select Pre-Designed siRNA, Applied Biosystems/Ambion, Austin, TX) using standard electrotransfection (10 6 cells/125 ll free-fetal bovine serum medium in a Bio-Rad gene pulser cuvette 0.2 cm, 250 V, 250 AF, infinite resistance). Following electroporation, samples were immediately combined with fresh culture medium and were plated and incubated at 37°C for 20 h. Then, cells were trypsinized and plated at 10 000 cells per well in 96-well plate with 2% fetal bovine serum, using three replicates for each condition. Remaining cells were plated in a 6-well plate to validate silencing by western blot. After 28 h, Caspase 3/7 activity was determined according to the manufacturer's instructions (Promega). Briefly, 100 ll of Caspase-GloÒ 3/7 Reagent was added to each well of 96-well plate containing 100 ll of blank (medium), control non-electroporated cells or siRNA-transfected cells in culture medium and incubated at room temperature for 1 h. Finally, we measured the luminescence of each sample in a plate-reading luminometer as indicated by the luminometer manufacturer. Background readings were determined from wells containing culture medium without cells, and mean values are the results of at least three independent experiments.
Results
Proteomic comparisons for the characterization of ERM/ETV5 regulated proteins in Hec-1A Stable transfectants were established in the human endometrial cancer cell line Hec-1A expressing the transcription factor ERM/ETV5 in fusion with the green fluorescent protein (GFP) and further compared with the non-transfected cell line and the Hec-1A cells stably expressing the empty vector with the GFP. As expected, immunofluorescence showed positive GFP staining in the Hec-1A GFP-expressing cells, localized in both the nucleus and the cytoplasm, and low nuclear ERM/ETV5 staining corresponding to the endogenous protein, similar to the non-transfected Hec-1A cells ( Figure 1A ). In contrast, Hec-1A GFP-ERM/ETV5-expressing cells showed mainly nuclear GFP fluorescence colocalizing with increased ERM/ETV5 signal that corresponded to both the transfected construct and the endogenous proteins ( Figure 1A) .
Protein extracts from the three cell lines were compared by 2D-DIGE technology. Triplicates of each cell line were extracted, cleared and purified as indicated (Materials and Methods), labeled with electrophilic forms of 1-(5-carboxypentyl)-1#-propylindocarbocyanine halide (Cy3) N-hydroxy-succinimidyl ester and 1-(5-carboxypentyl)-1#-methylindodi-carbocyanine halide (Cy5) N-hydroxysuccinimidyl ester fluorescent dyes and analyzed as mixtures. Analysis was repeated with reciprocal labeling. The proteins were separated in a 12.5% acrylamide gel after a linear gradient of pH 3-10 ( Figure 1B ). Approximately 2900 spots were detected in the gels, and statistical processing of the results considering a threshold of ±1.3-fold variation and a Pvalue ,0.005 rendered 60 spots differentially expressed in the ERM/ ETV5-overexpressing cell line compared with the two control cell lines ( Figure 1C-E) . Of those, 47 proteins could be identified by Maldi-TOF MS (Table I) .
Data mining using the Ingenuity pathway analysis software showed up cancer as the main biological alteration, principally focused on genes related to tumorigenesis. RNA posttranscriptional modification, mainly due to the upregulation of a group of heterogenous nuclear ribonucleoproteins, was also emphasized. Glycolisis/gluconeogenesis was stressed as the major canonical pathway altered, with ALDH1A1, ALDH7A1, ALDOA, HEP27, PGK1, PKM2 and TPI1 genes deregulated in ERM/ETV5-overexpressing Hec-1A cells. A more detailed analysis, based on gene interactions and molecular relationships, pointed to cell migration and invasion as the most relevantly perturbed biological processes upon the induction of the transcription factor ERM/ETV5: transforming growth factor beta (TGFb) and progesterone signaling, actin cytoskeleton regulation, annexin and tropomyosin modulation composed the main molecular network altered under the control of ERM/ETV5 in the Hec-1A endometrial cancer cell line ( Figure 2 ).
ERM/ETV5-dependent upregulation of mitochondrial Hep27
Among the upregulated proteins, Hep27 expression was found 12-and 10-fold increased compared with the control non-transfected and GFP-expressing Hec-1A cells, respectively. Hep27, a member of the SDR enzyme family, is a NADPH-dependent reductase enzyme active on cytotoxic a-dicarbonyl compounds (12) . The induction of Hep27 upon ERM/ETV5 overexpression was further validated by western blotting, confirming the notable induction of Hep27 concomitant to the expression of the fusion protein GFP-ERM/ETV5 and independently of the expression of the GFP or the unchanged levels of the endogenous ERM/ETV5 ( Figure 3A) .
To better understand the significance of the induction of Hep27 upon ERM/ETV5 overexpression, we analyzed the cellular localization of Hep27 in the Hec-1A GFP-ERM/ETV5-expressing cell line. As already described (13), Hep27 presented a faint punctuated nuclear pattern of expression ( Figure 3B ). In addition, a strong cytoplasmic labeling was found in some cells that overexpressed ERM/ETV5 ( Figure 3B ). On the contrary to this heterogenously distributed cytoplasmic profile, the faint punctuated nuclear labeling was homogenous throughout the cell culture ( Figure 3B ). Control non-transfected or GFP-expressing Hec-1A cells presented the same Hep27 nuclear pattern of expression, but the cytoplasmic staining was specific of the cells overexpressing ERM/ ETV5 (data not shown). Both immunofluorescence and citometry experiments showed that this pattern of expression was independent of the GFP-ERM/ETV5 levels of expression (data not shown). This cytoplasmic staining suggested that Hep27 could be localized at the mitochondria, and thus, we performed subcellular fractionation in ERM/ETV5-overexpressing Hec-1A cells that confirmed the mitochondrial localization of Hep27 in addition to its nuclear profile ( Figure 3C ). We further analyzed by confocal immunofluorescence its colocalization with a specific marker of these organelles, showing a clear colocalization between Hep27 and mitotracker ( Figure 3D ).
In vivo characterization of Hep27 expression
We next investigated whether this pattern of expression was reproduced in tissue samples both from an in vivo model and human carcinoma. Hep27 immunoassaying was first performed in orthotopic tumors generated in nude mice by subcutaneous injection of the Hec-1A GFP-ERM/ETV5, Hec-1A GFP and untransfected Hec-1A cell lines and subsequent implantation onto the posterior face of the uterus (7). As can be observed, the heterogenous pattern of Hep27 expression with a marked cytoplasmic staining in a reduced number of cells and a homogeneously distributed nuclear labeling was reproduced in in vivo conditions (Figure 4 ; upper panels). In addition, and compared with the orthotopic tumors generated from the control cell lines, those originated from the GFP-ERM/ETV5 Hec-1A cells showed an increased number of cells presenting the mitochondrial pattern, translating to an in vivo model the results obtained in vitro on the ERM/ ETV5-dependent induction of Hep27 (Figure 4 ; lower left panel). Next, the pattern of Hep27 expression was analyzed in representative samples of EECs where ERM/ETV5 was found to be related to the initial steps of myometrial infiltration and dissemination (6). This confirmed the diffuse staining at the cytoplasm and nucleus and the presence of isolated cells with a marked cytoplasmic labeling compatible with the mitochondria profile characterized in the cell cultures (lower right panel; Figure 4 ).
Oxidative stress associated with the upregulation of ERM/ETV5
The mitochondrial localization of Hep27 as well as the role that SDR plays in oxidative stress (12, 14) , together with the involvement of reactive oxygen species (ROS) in cell adhesion and migration (15) , prompted us to analyze the production of ROS in the different cell lines. For this, we incubated ERM/ETV5-transfected and non-transfected Hec-1A cells with the probe DHE; cytosolic DHE displays blue fluorescence, whereas after oxidation of this probe to ethidium, it
intercalates into cell's DNA strands, staining the nucleus with a bright red fluorescence. As it can be observed in Figure 5A , Hec-1A cells overexpressing ERM/ETV5 displayed more ROS, thus linking promoted cell migratory capacities with oxidative stress, in this cell line. The quantitative evaluation of the superoxide by flow cytometry rendered statistical significance to the oxidative stress promoted by the overexpression of ERM/ETV5 and its concomitant invasive capabilities (223.43 mean value for Hec-1A cells versus 399.00 mean value for Hec-1A GFP-ERM/ETV5 cells; P 5 0.0079 Student's t-test; Figure 5B ).
Protective role of Hep27 in response to oxidative stress generated by the upregulation of ERM/ETV5 To investigate a functional link between ERM/ETV5 overexpression and Hep27 upregulation, we first analyzed by chromatin immunoprecipitation whether the transcription factor ERM/ETV5 binds to the promoter of Hep27. Second, and based on the mitochondrial localization of Hep27 as well as its active role in inactivation of cytotoxic a-dicarbonyl xenobiotics that are generated through oxidative stress, we evaluated the response of both proteins to oxidative stress and an eventual role of Hep27 in the protection against apoptosis.
Chromatin immunoprecipitation was performed by immunoprecipitation with ERM/ETV5 mAb in the Hec-1A GFP-ERM/ETV5 cell line as described elsewhere (7) . PCR amplification clearly demonstrated that ERM/ETV5 specifically binds to the upstream region of the Hep27 gene, where two putative Ets-binding sites were identified by bioinformatic prediction ( Figure 6A ). These results suggested that the upregulation of Hep27 found in the ERM/ETV5-overexpressing endometrial cancer cells could be induced by direct binding of ERM/ ETV5 to its promoter region.
To explore the possibility that this direct link could be related to oxidative stress, Hec-1A cells overexpressing ERM/ETV5 were Proteomic approach to endometrial carcinoma invasion Protein was identified by ion trap mass spectrometer.
M.Monge et al.
exposed to 1 mM concentrations of the H 2 O 2 oxidizing agent. This resulted in an increase of both endogenous and the GFP fusion ERM/ ETV5, concomitant to that of Hep27 ( Figure 6B ). Conversely, when exposed to the antioxidant agent N-acetyl-L-cystein, both proteins dramatically decreased ( Figure 6B ). All these data suggested a role for ERM/ETV5 in the induction of Hep27 as a protective response to the oxidative stress generated by the enhanced invasive capabilities of the ERM/ETV5-overexpressing cells; the stress-increased Hep27 reductase activity can cope with the stress-induced formation of cytotoxic a-dicarbonyls (12, 14) .
To finally validate this hypothesis, we sought to demonstrate the protective role of Hep27 in the invasive ERM/ETV5-overexpressing cells, by silencing Hep27 expression and evaluating apoptosis induction. Two different siRNA (Hep27 #1 siRNA: s19887 and Hep27 #2 siRNA: s19888; see Materials and Methods) inhibited Hep27 expression at 80 and 67%, respectively (western blot in Figure 6C ). Apoptosis induction, quantified by a caspase-activity assay, was significantly increased when Hep27 expression was silenced ( ÃÃÃ P 5 0.0004; one-way analysis of variance Kruskal-Wallis test; histogram in Figure 6C ), thus confirming the protective role of this SDR during the promotion of invasion in the endometrial cancer cell line Hec-1A.
Discussion
In the present work, we analyzed the proteome associated with ERM/ ETV5 upregulation during myometrial infiltration in endometrial carcinoma. We used highly sensitive 2D-DIGE technology that involve labeling proteins from different samples with different fluorescent dyes, size matched and charge matched as well as spectrally distinct. This allows coseparation of different DIGE fluor-labeled samples in the same gel and ensures that all samples will be subjected to exactly the same first-and second-dimension electrophoresis running conditions, limiting experimental variation and ensuring accurate within gel matching. In addition, an internal standard resulting from the pooling of aliquots of all biological samples in the experiment permits normalization and accurate quantitative comparisons. Endometrial cancer cells stably overexpressing ERM/ETV5 were compared with both control non-transfected cells and cells transfected with the empty vector. Around 50 proteins under the presumptive control of ERM/ ETV5 could be identified by MALDI-TOF MS (Table I) .
Data mining founded on gene interactions and molecular relationships with the aim of detecting those biological processes relevantly perturbed upon the induction of the transcription factor ERM/ETV5, pointed to cellular migration and invasion as the main molecular Table I .
Proteomic approach to endometrial carcinoma invasion network altered through TGFb and progesterone signaling and actin cytoskeleton regulation. Nevertheless, exhaustive work must be done to confirm the significance of these pathways in relation to the role of ERM/ETV5 during tumor invasion. Previous work from the group described ERM/ETV5 upregulation in endometrial cancer to correlate with the degree of myometrial infiltration (6) . More recently, in vitro and in vivo results demonstrated ERM/ETV5 to act through matrix metalloproteinase-2 to confer the migratory and invasive capabilities associated with an initial switch to myometrial infiltration (7) . In addition to the well-known growth inhibiting effect of progesterone on endometrial cancer, progesterone and its receptors play an important role in regulating invasive properties of endometrial cancer cells (16) . It is also well known that the actin network is reorganized during cancer cell migration and invasion (17) . Molecules that link migratory Proteomic approach to endometrial carcinoma invasion signals to the actin cytoskeleton are upregulated in invasive and metastatic cancer cells (18) . Moreover, membrane protrusions in response to migratory and chemotactic stimuli and focal extracellular matrix degradation by podosomes and invadopodia are related to localized polymerization of submembrane actin filaments (19) . Finally, hormone-dependent migration in endometrial cancer cells was related to dissolution of stress fibers, dynamic actin accumulation at the cell periphery and formation of lamellipodia, filopodia and membrane spikes (20) . Regarding TGFb, and in the context of its dual role as a tumor suppressor and pro-oncogenic factor, it can exert effects on tumor and stromal cells in advanced disease stages to stimulate invasion, angiogenesis and metastasis and to inhibit immune surveillance (21) . These evidences support new therapeutic strategies targeting TGFb signaling as a basis for inhibiting its activity as an autocrine tumor-promoting factor that enhances cancer invasion and metastasis (22) . Concerning endometrial tumor invasion, disturbances of the TGFb signaling as well as localization of SMADs may be important to the infiltration of the myometrial wall by the type I endometrial carcinomas (23) . Moreover, myometrial invasion of endometrial cancers involves an increase in gelatinase activity regulated to some extent by TGFb 1 in an autocrine or paracrine fashion (24) .
The gene expression fold change of significantly altered genes under the control of ERM/ETV5 ranged 1.3-2, which represents reasonable changes in protein expression for a cell line stably expressing a transcription factor. Nonetheless, the most altered gene showed .10-fold induction in the ERM/ETV5-overexpressing cell line. Hep27, a member of the superfamily of SDR, was first identified in human hepatoblastoma HepG2 cells (11) . The important induction of this gene associated with the upregulation of ERM/ETV5 was further confirmed by western blot analysis in the endometrial cancer cell lines generated and its both nuclear and cytoplasmic localization corresponded to that described in the HepG2 cells (13) . Protein subcellular distribution may depend from sequence signals or patch signals and on protein interactions.
The fact that Hep27 was localized at the mitochondria suggested a physiological function linked to oxidative stress. ROS have been proposed to be involved in tumor metastasis as mediators of key genes relevant to cell adhesion, epithelial-mesenchymal transition and migration (15) . And indeed, we observed increased levels of ROS in the ERM/ETV5-overexpressing cells, indicative of an association between the enhanced migratory capacities of this cell line and the generation of oxidative stress. Alternatively, ROS have also been demonstrated to induce apoptosis, cell cycle arrest and cellular senescence through the uncoupling of the electron transport chain in mitochondria and to a decrease in mitochondrial membrane potential (25) . Interestingly, in tumor cells ROS may be an important factor in directly regulating the expression of ets-1, the founder member of the Ets family of transcription factors to which ERM/ETV5 belongs (26) . Indeed, ets-1 regulation of matrix metalloproteinase-1 expression has been described to be redox sensitive (27) . Likewise, H 2 O 2 -induced angiogenesis has been shown to be mediated by ets-1 (28), as well as angiotensin II-induced imflammation (29) . Finally, in Down's syndrome and Alzheimer's disease (30) or in high-cholesterol diet-induced atherosclerosis (31), oxidative stress has also been related to upregulation of diverse ets transcription factors. Likewise, in this study, we demonstrated that exogenous H 2 O 2 is capable of inducing an increase in ERM/ETV5 protein in the Hec-1A endometrial cancer cell line. Antioxidant treatment led to a decrease in ERM/ETV5 expression, indicating that the oxidative stress-induced response was probably specific.
The concomitant regulation of Hep27 gene through the direct binding of ETV5 to its promoter region suggests a contribution to protect mitochondria from the cytotoxic effect of a-dicarbonyl compounds. These reactive dicarbonyls, which are generated through oxidative stress (or are found as dietary constituents), can be cytotoxic causing chromosome loss (12) or processed into advanced glycation endproducts that are thought to cause complex underlying pathologies, including inflammation or sclerotic effects found in chronic diseases (14) . Accordingly, Hep27 could play an important role as scavenging enzymes of reactive a-dicarbonyls. To this regard, microarray analysis to identify putative targets of Ets-1 described enzymes involved in antioxidant defense by quenching the effects of the oxidative stress (32) . In this work, we could demonstrate a protective role for Hep27 against the oxidative stress generated by the overexpression of ERM/ ETV5 and the enhanced invasive properties associated with this transcription factor during endometrial carcinoma invasion.
In conclusion, the analysis of proteins under the control of ETV5 in the Hec-1A cell line reinforces a role of this transcription factor in the regulation of the migratory and invasive tumor behavior in endometrial cancer. We further characterized a role for ETV5 in a modulated response to oxidative stress associated with the promotion of invasion in endometrial cancer. Our results contribute to unravel the molecular events in EEC associated with the initiation of tumor invasion. In addition to represent an improvement in the pursuit of rational targets for the onset of metastasis, this knowledge would also be a valuable tool for the molecular stratification of patients since myometrial affectation determines an increase in the rate of recurrence after a first surgical treatment and a decrease in survival at the 5 year follow-up.
